Carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of thymic carcinoma

Thymic carcinoma is a relatively rare type of malignant tumor. The present retrospective study evaluated the efficacy and safety of carboplatin plus nanoparticle albumin-bound paclitaxel for the treatment of advanced thymic carcinoma. The study included data from 12 patients with advanced thymic car...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Akiko, Noro, Rintaro, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Fukuizumi, Aya, Omori, Miwako, Sugano, Teppei, Takeuchi, Susumu, Nakamichi, Shinji, Miyanaga, Akihiko, Minegishi, Yuji, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892466/
https://www.ncbi.nlm.nih.gov/pubmed/35251638
http://dx.doi.org/10.3892/mco.2022.2520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892466/
https://www.ncbi.nlm.nih.gov/pubmed/35251638
http://dx.doi.org/10.3892/mco.2022.2520

Ejemplares similares